The DOI matches its Crossref record.
Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors
Open accessAbstract
BACKGROUND: Inhibin is an ovarian hormone that inhibits the secretion of follicle-stimulating hormone (FSH) by the anterior pituitary gland. Women with granulosa-cell tumors of the ovary have elevated serum inhibin concentrations, but whether the concentrations are increased in women with other ovarian tumors is unknown. METHODS: We measured serum inhibin and FSH concentrations before surgery in 212 postmenopausal women with suspected ovarian cancer and after surgery in 210 of them. RESULTS: Eighteen of the 22 women (82 percent) with mucinous carcinomas (mucinous cystadenocarcinomas and mucinous borderline cystic tumors) of the ovary had elevated serum inhibin concentrations, whereas only 9 of the 53 women (17 percent) with serous carcinomas (serous cystadenocarcinomas and serous borderline cystic tumors) had elevated levels. Serum inhibin concentrations were also elevated in 2 of 12 women (17 percent) with clear-cell carcinomas, 4 of 26 women (15 percent) with undifferentiated carcinomas, 3 of 3 women (100 percent) with granulosa-cell tumors, and 5 of 27 women (19 percent) with other ovarian cancers. The serum concentrations of inhibin were increased in 2 of 28 women (7 percent) with nonovarian pelvic cancers and 11 of 41 women (27 percent) with benign ovarian diseases. All women but one with initially elevated serum inhibin concentrations had low values one week after surgery. Serum inhibin concentrations correlated negatively with serum FSH concentrations (P = 0.05) in women with granulosa-cell tumors but not in women with other tumors, suggesting that the inhibin secreted by tumors in the latter group has decreased biologic activity. CONCLUSIONS: Serum inhibin concentrations are elevated in most postmenopausal women with mucinous carcinomas of the ovary and in some women with other types of epithelial ovarian tumors. The concentrations fall after tumor removal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*
Auersperg, N., Wong, A. S. T., Choi, K.-C., Kang, S. K., & Leung, P. C. K. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0422 · Cited by 1,046
Zamboni, G., Scarpa, A., Bogina, G., Iacono, C., Bassi, C., Talamini, G., Sessa, F., Capella, C., Solcia, E., Rickaert, F., et al. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199904000-00005 · Cited by 682
Granulosa Cell Tumor of the Ovary
Schumer, S. T., & Cannistra, S. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.019 · Cited by 674
La Marca, A., & Volpe, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02533.x · Cited by 369
Management of Ovarian Stromal Cell Tumors
Colombo, N., Parma, G., Zanagnolo, V., & Insinga, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1005 · Cited by 326
Metadata
- Authors
- Healy, D. L., Burger, H. G., Mamers, P., Jobling, T., Bangah, M., Quinn, M., Grant, P., Day, A. J., Rome, R., & Campbell, J. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1993-11-18
- Volume
- 329
- Issue
- 21
- Pages
- 1539-1542
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2033162087
- Cited by
- 221
- References
- 0
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors. https://app.cochat.ai/papers/10.1056/nejm199311183292104
- The paper
- Healy, D. L., Burger, H. G., Mamers, P., Jobling, T., Bangah, M., Quinn, M., Grant, P., Day, A. J., Rome, R., & Campbell, J. J. (1993). Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors. New England Journal of Medicine. https://doi.org/10.1056/nejm199311183292104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.